Advertisement

Topics

Topas Therapeutics GmbH: Topas Therapeutics Signs Multi-Year Research And Option Agreement With Lilly Focused On Immune Tolerance

06:32 EDT 22 Aug 2017 | FinanzNachrichten

Work will utilize Topas' novel approach for antigen-specific tolerance induction Lilly has option to in-license and further develop drug candidates produced under the collaboration HAMBURG, GERMAN...

Original Article: Topas Therapeutics GmbH: Topas Therapeutics Signs Multi-Year Research And Option Agreement With Lilly Focused On Immune Tolerance

NEXT ARTICLE

More From BioPortfolio on "Topas Therapeutics GmbH: Topas Therapeutics Signs Multi-Year Research And Option Agreement With Lilly Focused On Immune Tolerance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...